DURECT Corporation to Present at Upcoming Life Sciences Conferences
CUPERTINO, CA-
July 10, 2006
DURECT Corporation (NASDAQ: DRRX) announced today that it will present a corporate overview at two upcoming life sciences conferences.
- Leerink Swann & Company/MEDA Corp Pain Roundtable Conference: Monday, July 10, 2006 at the Le Parker Meridien, Hotel in New York, NY at 10:15AM EST.
- C.E. Unterberg, Towbin Emerging Growth Conference: Tuesday, July 11, 2006 at The Mandarin Oriental Hotel in New York, NY at 1:22PM EST.
A live audio webcast of the presentations will be available by accessing DURECT’s homepage at http://www.durect.comand clicking “Investor Relations”.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company focused on the development of pharmaceutical systems based on its proprietary drug delivery platform technologies. The company is developing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time to treat chronic and episodic diseases and conditions.
SOURCE DURECT Corporation
CONTACT: Schond L. Greenway, Vice President, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417
|
|
